XY-4

XY-4 is a chemically modified analog of 2-palmitoyl lysophosphatidic acid (LPA), featuring two fluorine atoms in place of the hydroxyl group at the sn-1 position. This structural alteration gives the molecule potent activity as a selective pharmacological agent. It functions as an antagonist or inverse agonist specifically targeting the LPA1, LPA2, and LPA3 receptor subtypes.

474329-47-0

XY-4 (PPARγ agonist); [(2R)-1,1-Difluoro-3-phosphonooxypropan-2-yl] hexadecanoate; CHEMBL195383; SCHEMBL14513719; PPARy selective ligand, L-1160; Hexadecanoic acid (R)-2,2-difluoro-1-phosphonooxymethyl-ethyl ester

C₁₉H₃₇F₂O₆P

430.46

InChI=1S/C19H37F2O6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(22)27-17(19(20)21)16-26-28(23,24)25/h17,19H,2-16H2,1H3,(H2,23,24,25)/t17-/m1/s1

FNESAIQQDLSXRX-QGZVFWFLSA-N

Min 95%

Dried by centrifugal evaporation from a solution.

Conforms to structure

Store at -20°C for long term storage.